Georgia Chenevix-Trench
#88,731
Most Influential Person Now
Australian scientist
Georgia Chenevix-Trench's AcademicInfluence.com Rankings
Georgia Chenevix-Trenchchemistry Degrees
Chemistry
#4168
World Rank
#5232
Historical Rank
Chemical Engineering
#507
World Rank
#526
Historical Rank
Organic Chemistry
#671
World Rank
#766
Historical Rank
Download Badge
Chemistry
Georgia Chenevix-Trench's Degrees
- Bachelors Chemistry University of Melbourne
Why Is Georgia Chenevix-Trench Influential?
(Suggest an Edit or Addition)According to Wikipedia, Georgia Chenevix-Trench is an Australian cancer researcher who investigates genetic predispositions to cancer. Chenevix-Trench was born in Nairobi, Kenya. She received her undergraduate degree in 1980 from the department of genetics at Trinity College in Ireland and was subsequently awarded her PhD in 1985 from the department of human genetics at the Medical College of Virginia, USA. and in 1986 she commenced her post-doctoral work there. In 1989 she moved to Australia where she started working as a research officer at the Queensland Institute of Medical Research . She currently works at the QIMR Berghofer Medical Research Institute, where she heads a cancer genetics research lab.
Georgia Chenevix-Trench's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Mutations of the BRAF gene in human cancer (2002) (9903)
- Patterns of somatic mutation in human cancer genomes (2007) (3038)
- Genome-wide association study identifies novel breast cancer susceptibility loci (2007) (2351)
- Mutations of the Human Homolog of Drosophila patched in the Nevoid Basal Cell Carcinoma Syndrome (1996) (1990)
- Large-scale genotyping identifies 41 new loci associated with breast cancer risk (2013) (1063)
- Association analysis identifies 65 new breast cancer risk loci (2017) (922)
- Lung cancer: Intragenic ERBB2 kinase mutations in tumours (2004) (780)
- Gene-panel sequencing and the prediction of breast-cancer risk. (2015) (747)
- A common coding variant in CASP8 is associated with breast cancer risk (2007) (591)
- Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes (2018) (559)
- MicroRNA Related Polymorphisms and Breast Cancer Risk (2014) (557)
- Association between BRCA1 and BRCA2 mutations and survival in women with invasive epithelial ovarian cancer. (2012) (544)
- Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies. (2011) (536)
- Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer (2013) (534)
- Parent-of-origin specific allelic associations among 106 genomic loci for age at menarche (2014) (511)
- Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2 (2009) (502)
- Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer (2015) (502)
- Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants (2015) (471)
- Frequent PTEN/MMAC mutations in endometrioid but not serous or mucinous epithelial ovarian tumors. (1998) (456)
- Pathology of Breast and Ovarian Cancers among BRCA1 and BRCA2 Mutation Carriers: Results from the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA) (2011) (447)
- CHEK2*1100delC and susceptibility to breast cancer: a collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies. (2004) (442)
- Genome-wide association studies identify four ER negative–specific breast cancer risk loci (2013) (411)
- Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk (2013) (405)
- Medulloblastomas of the desmoplastic variant carry mutations of the human homologue of Drosophila patched. (1997) (397)
- Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer. (2015) (390)
- Heterogeneity of Breast Cancer Associations with Five Susceptibility Loci by Clinical and Pathological Characteristics (2008) (390)
- RAD51B in Familial Breast Cancer (2016) (366)
- Genomic analyses identify hundreds of variants associated with age at menarche and support a role for puberty timing in cancer risk (2017) (359)
- A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor–negative breast cancer in the general population (2010) (357)
- Large-scale association analysis identifies new lung cancer susceptibility loci and heterogeneity in genetic susceptibility across histological subtypes (2017) (353)
- GWAS meta-analysis and replication identifies three new susceptibility loci for ovarian cancer (2013) (350)
- A genome-wide association study identifies susceptibility loci for ovarian cancer at 2q31 and 8q24 (2010) (341)
- Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study. (2013) (339)
- Breast Cancer Risk Genes - Association Analysis in More than 113,000 Women. (2020) (322)
- Large-scale genomic analyses link reproductive ageing to hypothalamic signaling, breast cancer susceptibility and BRCA1-mediated DNA repair (2015) (308)
- Nevoid basal cell carcinoma syndrome: review of 118 affected individuals. (1994) (307)
- A genome-wide association study identifies a new ovarian cancer susceptibility locus on 9p22.2 (2009) (305)
- Genome-wide association analysis identifies three new breast cancer susceptibility loci (2012) (291)
- Most germ-line mutations in the nevoid basal cell carcinoma syndrome lead to a premature termination of the PATCHED protein, and no genotype-phenotype correlations are evident. (1997) (278)
- RAD51 135G-->C modifies breast cancer risk among BRCA2 mutation carriers: results from a combined analysis of 19 studies. (2007) (276)
- Dominant negative ATM mutations in breast cancer families. (2002) (275)
- The OncoArray Consortium: A Network for Understanding the Genetic Architecture of Common Cancers (2016) (267)
- Common variants at 19p13 are associated with susceptibility to ovarian cancer (2010) (262)
- A recurrent germline PAX5 mutation confers susceptibility to pre-B cell acute lymphoblastic leukemia (2013) (253)
- Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer (2017) (244)
- Common breast cancer-predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers. (2008) (238)
- Dose-Response Association of CD8+ Tumor-Infiltrating Lymphocytes and Survival Time in High-Grade Serous Ovarian Cancer (2017) (237)
- Functional variants at the 11q13 risk locus for breast cancer regulate cyclin D1 expression through long-range enhancers. (2013) (225)
- Incessant ovulation, inflammation and epithelial ovarian carcinogenesis: Revisiting old hypotheses (2006) (216)
- Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA1 and BRCA2 Mutation Carriers (2017) (211)
- Glutathione S-transferase M1 and T1 polymorphisms: susceptibility to colon cancer and age of onset. (1995) (210)
- Mutational spectrum in a worldwide study of 29,700 families with BRCA1 or BRCA2 mutations (2018) (206)
- Isolation and characterization of human patched 2 (PTCH2), a putative tumour suppressor gene inbasal cell carcinoma and medulloblastoma on chromosome 1p32. (1999) (206)
- Genetically Predicted Body Mass Index and Breast Cancer Risk: Mendelian Randomization Analyses of Data from 145,000 Women of European Descent (2016) (205)
- Genetic and histopathologic evaluation of BRCA1 and BRCA2 DNA sequence variants of unknown clinical significance. (2006) (201)
- Rare variants in the ATM gene and risk of breast cancer (2011) (200)
- Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families. (2019) (196)
- Common breast cancer susceptibility alleles and the risk of breast cancer for BRCA1 and BRCA2 mutation carriers: implications for risk prediction. (2010) (196)
- Low penetrance breast cancer susceptibility loci are associated with specific breast tumor subtypes: findings from the Breast Cancer Association Consortium. (2011) (192)
- Cleft lip with or without cleft palate: associations with transforming growth factor alpha and retinoic acid receptor loci. (1992) (191)
- Point Mutations in Exon 1B of APC Reveal Gastric Adenocarcinoma and Proximal Polyposis of the Stomach as a Familial Adenomatous Polyposis Variant. (2016) (191)
- Gastric adenocarcinoma and proximal polyposis of the stomach (GAPPS): a new autosomal dominant syndrome (2011) (185)
- Identification of Novel Genetic Markers of Breast Cancer Survival (2015) (185)
- ABCA transporter gene expression and poor outcome in epithelial ovarian cancer. (2014) (177)
- Identification of six new susceptibility loci for invasive epithelial ovarian cancer (2014) (176)
- The BRCA1-Δ11q Alternative Splice Isoform Bypasses Germline Mutations and Promotes Therapeutic Resistance to PARP Inhibition and Cisplatin. (2016) (176)
- PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS (2016) (174)
- Interplay between BRCA1 and RHAMM Regulates Epithelial Apicobasal Polarization and May Influence Risk of Breast Cancer (2011) (174)
- An international initiative to identify genetic modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: the Consortium of Investigators of Modifiers of BRCA1 and BRCA2 (CIMBA) (2007) (173)
- Rare, evolutionarily unlikely missense substitutions in ATM confer increased risk of breast cancer. (2009) (170)
- A single nucleotide polymorphism in the 5' untranslated region of RAD51 and risk of cancer among BRCA1/2 mutation carriers. (2001) (167)
- Epigenetic analysis leads to identification of HNF1B as a subtype-specific susceptibility gene for ovarian cancer (2013) (167)
- Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource (2006) (163)
- Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers. (2016) (154)
- Common Genetic Variants and Modification of Penetrance of BRCA2-Associated Breast Cancer (2010) (154)
- A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer (2018) (149)
- Genomic instability occurs in colorectal carcinomas but not in adenomas (1993) (147)
- Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types. (2016) (146)
- A genome wide linkage search for breast cancer susceptibility genes (2006) (146)
- β‐Catenin mutation and expression analysis in ovarian cancer: Exon 3 mutations and nuclear translocation in 16% of endometrioid tumours (1999) (145)
- The CYP3A4*1B polymorphism has no functional significance and is not associated with risk of breast or ovarian cancer. (2002) (143)
- Prediction of Breast and Prostate Cancer Risks in Male BRCA1 and BRCA2 Mutation Carriers Using Polygenic Risk Scores (2017) (142)
- Germline Mutation in BRCA1 or BRCA2 and Ten-Year Survival for Women Diagnosed with Epithelial Ovarian Cancer (2014) (135)
- Breast cancer stem cells: treatment resistance and therapeutic opportunities. (2011) (131)
- HER3 and downstream pathways are involved in colonization of brain metastases from breast cancer (2010) (130)
- Analysis of gene amplification in head‐and‐neck squamous‐cell carcinomas (1991) (127)
- Genome-wide association analysis of coffee drinking suggests association with CYP1A1/CYP1A2 and NRCAM (2011) (127)
- Tumour-specific distribution of BRCA1 promoter region methylation supports a pathogenetic role in breast and ovarian cancer. (2000) (126)
- A genome-wide association scan (GWAS) for mean telomere length within the COGS project: identified loci show little association with hormone-related cancer risk (2013) (125)
- Somatic and germline mutations of the BRCA2 gene in sporadic ovarian cancer. (1996) (125)
- Gene expression profiling of tumour epithelial and stromal compartments during breast cancer progression (2012) (124)
- Common variants in LSP1, 2q35 and 8q24 and breast cancer risk for BRCA1 and BRCA2 mutation carriers. (2009) (124)
- Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170 (2016) (122)
- Identification of a BRCA2-Specific Modifier Locus at 6p24 Related to Breast Cancer Risk (2013) (120)
- Genetic determinants of telomere length and risk of common cancers: a Mendelian randomization study (2015) (119)
- Risk of estrogen receptor-positive and -negative breast cancer and single-nucleotide polymorphism 2q35-rs13387042. (2009) (116)
- Mutation of ERBB2 Provides a Novel Alternative Mechanism for the Ubiquitous Activation of RAS-MAPK in Ovarian Serous Low Malignant Potential Tumors (2008) (116)
- 19p13.1 is a triple-negative-specific breast cancer susceptibility locus. (2012) (115)
- Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation (2014) (112)
- DNA Glycosylases Involved in Base Excision Repair May Be Associated with Cancer Risk in BRCA1 and BRCA2 Mutation Carriers (2014) (112)
- Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses (2019) (110)
- Identification and molecular characterization of a new ovarian cancer susceptibility locus at 17q21.31 (2013) (110)
- Subtypes of familial breast tumours revealed by expression and copy number profiling (2010) (110)
- Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1. (2013) (109)
- CDX2, a human homologue of Drosophila caudal, is mutated in both alleles in a replication error positive colorectal cancer (1998) (108)
- Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization. (2015) (107)
- ABCB1 (MDR 1) Polymorphisms and Progression-Free Survival among Women with Ovarian Cancer following Paclitaxel/Carboplatin Chemotherapy (2008) (104)
- Refined histopathological predictors of BRCA1 and BRCA2mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia (2014) (103)
- Common breast cancer susceptibility alleles are associated with tumour subtypes in BRCA1 and BRCA2 mutation carriers: results from the Consortium of Investigators of Modifiers of BRCA1/2 (2011) (101)
- Kathleen Cuningham Foundation Consortium For Research Into Familial Breast Cancer (2008) (100)
- Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study (2010) (100)
- Polymorphisms at the glutathione S-transferase GSTM1, GSTT1 and GSTP1 loci: risk of ovarian cancer by histological subtype. (2001) (99)
- Classification of BRCA1 missense variants of unknown clinical significance (2005) (96)
- Association of vitamin D levels and risk of ovarian cancer: a Mendelian randomization study. (2016) (96)
- Design and analysis issues in a population-based, case-control-family study of the genetic epidemiology of breast cancer and the Co-operative Family Registry for Breast Cancer Studies (CFRBCS). (1999) (96)
- Association of ESR1 gene tagging SNPs with breast cancer risk. (2009) (95)
- Germ‐line mutations in BRCA1 or BRCA2 in the normal breast are associated with altered expression of estrogen‐responsive proteins and the predominance of progesterone receptor A (2004) (95)
- The role of genetic breast cancer susceptibility variants as prognostic factors. (2012) (95)
- Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer (2016) (95)
- Integrated genomic and transcriptomic analysis of human brain metastases identifies alterations of potential clinical significance (2015) (94)
- Tagging single nucleotide polymorphisms in cell cycle control genes and susceptibility to invasive epithelial ovarian cancer. (2007) (94)
- Double-Strand Break Repair Gene Polymorphisms and Risk of Breast or Ovarian Cancer (2005) (93)
- Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2 mutation carriers (2012) (92)
- Consortium analysis of 7 candidate SNPs for ovarian cancer (2008) (91)
- Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer (2018) (91)
- Associations of common variants at 1p11.2 and 14q24.1 (RAD51L1) with breast cancer risk and heterogeneity by tumor subtype: findings from the Breast Cancer Association Consortium. (2011) (90)
- Population‐based estimates of breast cancer risks associated with ATM gene variants c.7271T>G and c.1066–6T>G (IVS10–6T>G) from the Breast Cancer Family Registry (2006) (90)
- Most common 'sporadic' cancers have a significant germline genetic component. (2014) (88)
- ESR1/SYNE1 Polymorphism and Invasive Epithelial Ovarian Cancer Risk: An Ovarian Cancer Association Consortium Study (2010) (88)
- DNA methylome of familial breast cancer identifies distinct profiles defined by mutation status (2010) (88)
- Frequent loss of heterozygosity on chromosome 18 in ovarian adenocarcinoma which does not always include the DCC locus. (1992) (87)
- Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1. (2015) (86)
- Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2 (2016) (84)
- Further localization of the gene for nevoid basal cell carcinoma syndrome (NBCCS) in 15 Australasian families: linkage and loss of heterozygosity. (1993) (83)
- No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing (2016) (83)
- Androgen receptor exon 1 CAG repeat length and breast cancer in women before age forty years. (1999) (83)
- Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers. (2011) (82)
- Role of genetic polymorphisms and ovarian cancer susceptibility (2009) (82)
- Clinical classification of BRCA1 and BRCA2 DNA sequence variants: the value of cytokeratin profiles and evolutionary analysis--a report from the kConFab Investigators. (2008) (82)
- Further evidence for an association between genetic variation in transforming growth factor alpha and cleft lip and palate. (1991) (82)
- Genome-wide significant risk associations for mucinous ovarian carcinoma (2015) (81)
- Common breast cancer predisposition alleles are associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers (2008) (81)
- Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis. (2018) (80)
- Ovarian and Breast Cancer Risks Associated With Pathogenic Variants in RAD51C and RAD51D (2020) (80)
- CYP17 promoter polymorphism and breast cancer in Australian women under age forty years. (2000) (78)
- The molecular origin and taxonomy of mucinous ovarian carcinoma (2019) (78)
- Meta-analysis of the global gene expression profile of triple-negative breast cancer identifies genes for the prognostication and treatment of aggressive breast cancer (2014) (78)
- Pathology of Breast andOvarian Cancers among BRCA 1 and BRCA 2 Mutation Carriers : Results from the Consortium of Investigators of Modi fi ers of BRCA 1 / 2 ( CIMBA ) (2011) (78)
- Rad51 supports triple negative breast cancer metastasis (2014) (77)
- Common variants associated with breast cancer in genome-wide association studies are modifiers of breast cancer risk in BRCA1 and BRCA2 mutation carriers. (2010) (77)
- BRCA2 Polymorphic Stop Codon K3326X and the Risk of Breast, Prostate, and Ovarian Cancers. (2016) (76)
- Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer. (2009) (75)
- A genome-wide association study of caffeine-related sleep disturbance: confirmation of a role for a common variant in the adenosine receptor. (2012) (74)
- Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes (2019) (74)
- The Landscape of Somatic Genetic Alterations in Breast Cancers From ATM Germline Mutation Carriers. (2018) (74)
- Frequent loss of heterozygosity and three critical regions on the short arm of chromosome 8 in ovarian adenocarcinomas (1998) (74)
- A fine-scale dissection of the DNA double-strand break repair machinery and its implications for breast cancer therapy (2014) (74)
- Common chromosomal fragile site FRA16D mutation in cancer cells. (2005) (74)
- Frequent loss of heterozygosity on chromosome 14 occurs in advanced colorectal carcinomas. (1993) (72)
- Gene expression profiling of formalin‐fixed, paraffin‐embedded familial breast tumours using the whole genome‐DASL assay (2010) (72)
- Identification of BRCA1 missense substitutions that confer partial functional activity: potential moderate risk variants? (2007) (71)
- A role for common genomic variants in the assessment of familial breast cancer. (2012) (71)
- Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer (2017) (70)
- The Australian Ovarian Cancer Study (2012) (69)
- The BRCA2 372 HH genotype is associated with risk of breast cancer in Australian women under age 60 years. (2002) (69)
- Five Polymorphisms and Breast Cancer Risk: Results from the Breast Cancer Association Consortium (2009) (69)
- Treatment of Triple-Negative Breast Cancer Using Anti-EGFR–Directed Radioimmunotherapy Combined with Radiosensitizing Chemotherapy and PARP Inhibitor (2013) (69)
- Association Between Single-Nucleotide Polymorphisms in Hormone Metabolism and DNA Repair Genes and Epithelial Ovarian Cancer: Results from Two Australian Studies and an Additional Validation Set (2007) (69)
- A Novel Corepressor, BCoR-L1, Represses Transcription through an Interaction with CtBP* (2007) (69)
- Shared genetics underlying epidemiological association between endometriosis and ovarian cancer. (2015) (68)
- Distinct phenotype in maternal uniparental disomy of chromosome 14. (1994) (68)
- BRCA2 Hypomorphic Missense Variants Confer Moderate Risks of Breast Cancer. (2017) (67)
- Functional evidence for a colorectal cancer tumor suppressor gene at chromosome 8p22-23 by monochromosome transfer. (1996) (67)
- Shared heritability and functional enrichment across six solid cancers (2018) (67)
- Reduced expression of intercellular adhesion molecule-1 in ovarian adenocarcinomas (2001) (66)
- Targeted massively parallel sequencing of a panel of putative breast cancer susceptibility genes in a large cohort of multiple-case breast and ovarian cancer families (2015) (66)
- Evidence for a time-dependent association between FOLR1 expression and survival from ovarian carcinoma: implications for clinical testing. An Ovarian Tumour Tissue Analysis consortium study (2014) (65)
- Evaluation of Candidate Stromal Epithelial Cross-Talk Genes Identifies Association between Risk of Serous Ovarian Cancer and TERT, a Cancer Susceptibility “Hot-Spot” (2010) (64)
- Evidence that the 5p12 Variant rs10941679 Confers Susceptibility to Estrogen-Receptor-Positive Breast Cancer through FGF10 and MRPS30 Regulation (2016) (63)
- Common alleles in candidate susceptibility genes associated with risk and development of epithelial ovarian cancer (2011) (62)
- Gene expression in melanoma cell lines and cultured melanocytes: correlation between levels of c-src-1, c-myc and p53. (1990) (62)
- Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium (2014) (62)
- Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium (2014) (62)
- Progesterone receptor promoter +331A polymorphism is associated with a reduced risk of endometrioid and clear cell ovarian cancers. (2004) (61)
- Prognostic gene expression signature for high-grade serous ovarian cancer (2020) (61)
- Platinum Sensitivity–Related Germline Polymorphism Discovered via a Cell-Based Approach and Analysis of Its Association with Outcome in Ovarian Cancer Patients (2011) (61)
- Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC) (2012) (60)
- Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study. (2016) (60)
- Common Variants at the 19p13.1 and ZNF365 Loci Are Associated with ER Subtypes of Breast Cancer and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers (2012) (60)
- Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants (2020) (60)
- Fine genetic mapping of the gene for nevoid basal cell carcinoma syndrome. (1994) (59)
- Progesterone receptor variation and risk of ovarian cancer is limited to the invasive endometrioid subtype: results from the ovarian cancer association consortium pooled analysis (2008) (59)
- Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers (2014) (58)
- Heregulin-HER3-HER2 signaling promotes matrix metalloproteinase-dependent blood-brain-barrier transendothelial migration of human breast cancer cell lines (2015) (58)
- Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast–ovarian cancer susceptibility locus (2016) (58)
- ABCB1 (MDR1) polymorphisms and ovarian cancer progression and survival: a comprehensive analysis from the Ovarian Cancer Association Consortium and The Cancer Genome Atlas. (2013) (57)
- Expression of p53 in arsenic-related and sporadic basal cell carcinoma. (2000) (57)
- Molecular characterization and cancer risk associated with BRCA1 and BRCA2 splice site variants identified in multiple‐case breast cancer families (2005) (57)
- Association between a germline OCA2 polymorphism at chromosome 15q13.1 and estrogen receptor-negative breast cancer survival. (2010) (56)
- The Role of KRAS rs61764370 in Invasive Epithelial Ovarian Cancer: Implications for Clinical Testing (2011) (56)
- Evidence for an association between nonsyndromic cleft lip with or without cleft palate and a gene located on the long arm of chromosome 4. (1995) (55)
- A large, dominant pedigree of atrioventricular septal defect (AVSD): exclusion from the Down syndrome critical region on chromosome 21. (1993) (55)
- Genetic variation at 9p22.2 and ovarian cancer risk for BRCA1 and BRCA2 mutation carriers. (2011) (55)
- Traceback: A Proposed Framework to Increase Identification and Genetic Counseling of BRCA1 and BRCA2 Mutation Carriers Through Family-Based Outreach. (2017) (54)
- Loss of heterozygosity at chromosome segment Xq25‐26.1 in advanced human ovarian carcinomas (1997) (53)
- Functional Polymorphisms in the TERT Promoter Are Associated with Risk of Serous Epithelial Ovarian and Breast Cancers (2011) (53)
- Analysis of RAD51C germline mutations in high-risk breast and ovarian cancer families and ovarian cancer patients (2012) (53)
- Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer (2019) (53)
- Association of the Variants CASP8 D302H and CASP10 V410I with Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers (2010) (53)
- Association between invasive ovarian cancer susceptibility and 11 best candidate SNPs from breast cancer genome-wide association study. (2009) (53)
- Association of a common AKAP9 variant with breast cancer risk: a collaborative analysis. (2008) (52)
- The androgen receptor CAG repeat polymorphism and modification of breast cancer risk in BRCA1 and BRCA2 mutation carriers (2004) (52)
- Combined and Interactive Effects of Environmental and GWAS-Identified Risk Factors in Ovarian Cancer (2013) (52)
- Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk. (2015) (51)
- Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2 (2015) (50)
- Cis-eQTL analysis and functional validation of candidate susceptibility genes for high-grade serous ovarian cancer (2015) (50)
- Analysis of loss of heterozygosity and KRAS2 mutations in ovarian neoplasms: Clinicopathological correlations (1997) (50)
- Mutation analysis of FANCD2, BRIP1/BACH1, LMO4 and SFN in familial breast cancer (2005) (50)
- Fine deletion mapping on the long arm of chromosome 9 in sporadic and familial basal cell carcinomas. (1995) (50)
- Genetic Predisposition to In Situ and Invasive Lobular Carcinoma of the Breast (2014) (49)
- Systematic review with meta‐analysis: fundic gland polyps and proton pump inhibitors (2016) (49)
- BRCA2 arg372hispolymorphism and epithelial ovarian cancer risk (2003) (47)
- Ovarian cancer susceptibility alleles and risk of ovarian cancer in BRCA1 and BRCA2 mutation carriers (2012) (47)
- The role of glutathione-S-transferase polymorphisms in ovarian cancer survival. (2007) (47)
- Genetic, functional, and histopathological evaluation of two C-terminal BRCA1 missense variants (2005) (47)
- Genetic predisposition to ductal carcinoma in situ of the breast (2016) (46)
- Androgen receptor exon 1 cag repeat length and risk of ovarian cancer (2000) (46)
- kConFab: a research resource of Australasian breast cancer families (2000) (46)
- A Transcriptome-Wide Association Study Among 97,898 Women to Identify Candidate Susceptibility Genes for Epithelial Ovarian Cancer Risk. (2018) (45)
- Kinome profiling reveals breast cancer heterogeneity and identifies targeted therapeutic opportunities for triple negative breast cancer (2014) (45)
- Progesterone receptor polymorphisms and risk of breast cancer: results from two Australian breast cancer studies (2008) (45)
- Validating genetic risk associations for ovarian cancer through the International Ovarian Cancer Association Consortium (2009) (45)
- Rare mutations and no hypermethylation at the CDKN2A locus in epithelial ovarian tumours (1997) (45)
- Elevation of follicular phase inhibin and luteinizing hormone levels in mothers of dizygotic twins suggests nonovarian control of human multiple ovulation. (1991) (45)
- Cell-type-specific enrichment of risk-associated regulatory elements at ovarian cancer susceptibility loci. (2015) (45)
- DNA mismatch repair gene MSH6 implicated in determining age at natural menopause (2013) (44)
- Genome-wide association study of germline variants and breast cancer-specific mortality (2019) (44)
- De novo mutations of the Patched gene in nevoid basal cell carcinoma syndrome help to define the clinical phenotype. (1997) (44)
- No evidence for the H133Y mutation in SONIC HEDGEHOG in a collection of common tumour types (1998) (43)
- Breast cancer risk prediction using a polygenic risk score in the familial setting: a prospective study from the Breast Cancer Family Registry and kConFab (2016) (43)
- Low frequency of CHEK2 1100delC allele in Australian multiple-case breast cancer families: functional analysis in heterozygous individuals (2005) (43)
- Annexin A1 expression in a pooled breast cancer series: association with tumor subtypes and prognosis (2015) (43)
- CYP17 promotor polymorphism and ovarian cancer risk (2000) (43)
- Risk of ovarian cancer and the NF-κB pathway: genetic association with IL1A and TNFSF10. (2014) (42)
- The microsomal epoxide hydrolase Tyr113His polymorphism: Association with risk of ovarian cancer (2001) (42)
- Frequent loss of heterozygosity at 1p36 in ovarian adenocarcinomas but the gene encoding p73 is unlikely to be the target (1999) (42)
- Two ATM variants and breast cancer risk (2005) (42)
- Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers. (2011) (42)
- Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study (2017) (42)
- Allelic loss on chromosome 7q in ovarian adenocarcinomas: two critical regions and a rearrangement of the PLANH1 locus. (1996) (42)
- COMPLEXO: identifying the missing heritability of breast cancer via next generation collaboration (2013) (41)
- Basal cell carcinoma in chronic arsenicism occurring in Queensland, Australia, after ingestion of an asthma medication. (2000) (41)
- A Common Cancer Risk-Associated Allele in the hTERT Locus Encodes a Dominant Negative Inhibitor of Telomerase (2015) (41)
- A Systematic Approach to Analysing Gene-Gene Interactions: Polymorphisms at the Microsomal Epoxide Hydrolase EPHX and Glutathione S-transferase GSTM1, GSTT1, and GSTP1 Loci and Breast Cancer Risk (2007) (41)
- DHPLC Analysis of patients with Nevoid Basal Cell Carcinoma Syndrome reveals novel PTCH missense mutations in the sterol‐sensing domain (2005) (40)
- ATM and Genome Maintenance: Defining Its Role in Breast Cancer Susceptibility (2004) (40)
- A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium. (2014) (40)
- No significant association between progesterone receptor exon 4 Val660Leu G/T polymorphism and risk of ovarian cancer. (2001) (40)
- Folate and related micronutrients, folate-metabolising genes and risk of ovarian cancer (2011) (40)
- Characterization of the Cancer Spectrum in Men With Germline BRCA1 and BRCA2 Pathogenic Variants: Results From the Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA). (2020) (40)
- Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants (2022) (39)
- Decreased expression of the Id3 gene at 1p36.1 in ovarian adenocarcinomas (2001) (39)
- Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women (2016) (39)
- Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression. (2015) (39)
- Modification of ovarian cancer risk by BRCA1/2-interacting genes in a multicenter cohort of BRCA1/2 mutation carriers. (2009) (39)
- Loss of heterozygosity on the long arm of chromosome 11 in colorectal tumours. (1994) (38)
- Basal cell carcinomas, coarse sparse hair, and milia. (1992) (38)
- 11q13 is a susceptibility locus for hormone receptor positive breast cancer (2012) (38)
- Missense Variants in ATM in 26,101 Breast Cancer Cases and 29,842 Controls (2010) (38)
- Body mass index and breast cancer survival: a Mendelian randomization analysis (2017) (38)
- Fine‐scale mapping of 8q24 locus identifies multiple independent risk variants for breast cancer (2016) (38)
- Relationship between number of ovulatory cycles and accumulation of mutant p53 in epithelial ovarian cancer. (1998) (37)
- Assessing Associations between the AURKA-HMMR-TPX2-TUBG1 Functional Module and Breast Cancer Risk in BRCA1/2 Mutation Carriers (2015) (37)
- Comparison of Expression Profiles in Ovarian Epithelium In Vivo and Ovarian Cancer Identifies Novel Candidate Genes Involved in Disease Pathogenesis (2011) (37)
- AURKA F31I Polymorphism and Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers: A Consortium of Investigators of Modifiers of BRCA1/2 Study (2007) (37)
- Assessment of Hepatocyte Growth Factor in Ovarian Cancer Mortality (2011) (37)
- Network-Based Integration of GWAS and Gene Expression Identifies a HOX-Centric Network Associated with Serous Ovarian Cancer Risk (2015) (36)
- Analysis of the candidate 8p21 tumour suppressor, BNIP3L, in breast and ovarian cancer (2003) (36)
- An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression. (2016) (35)
- Combined Associations of a Polygenic Risk Score and Classical Risk Factors With Breast Cancer Risk (2020) (35)
- Sequence variants of DLC1 in colorectal and ovarian tumours (2000) (35)
- Investigation of gene‐environment interactions between 47 newly identified breast cancer susceptibility loci and environmental risk factors (2015) (35)
- Mapping of a candidate colorectal cancer tumor‐suppressor gene to a 900‐kilobase region on the short arm of chromosome 8 (2004) (35)
- CYP17 genetic polymorphism, breast cancer, and breast cancer risk factors: Australian Breast Cancer Family Study (2005) (34)
- Variation in the RAD51 gene and familial breast cancer (2006) (34)
- Germline polymorphisms in an enhancer of PSIP1 are associated with progression-free survival in epithelial ovarian cancer (2016) (34)
- Common genetic variants and cancer risk in Mendelian cancer syndromes. (2010) (34)
- Association of Genomic Domains in BRCA1 and BRCA2 with Prostate Cancer Risk and Aggressiveness. (2019) (33)
- Frequent somatic mutations of GATA3 in non-BRCA1/BRCA2 familial breast tumors, but not in BRCA1-, BRCA2- or sporadic breast tumors (2008) (33)
- Colorectal carcinomas show frequent allelic loss on the long arm of chromosome 17 with evidence for a specific target region. (1995) (33)
- Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21 (2016) (33)
- Confirmation of 5p12 As a Susceptibility Locus for Progesterone-Receptor–Positive, Lower Grade Breast Cancer (2011) (33)
- Identification of New Genetic Susceptibility Loci for Breast Cancer Through Consideration of Gene‐Environment Interactions (2014) (33)
- Evolutionary conservation analysis increases the colocalization of predicted exonic splicing enhancers in the BRCA1 gene with missense sequence changes and in-frame deletions, but not polymorphisms (2005) (33)
- Evidence of a genetic link between endometriosis and ovarian cancer. (2016) (33)
- Xenobiotic‐Metabolizing gene polymorphisms and ovarian cancer risk (2011) (32)
- Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus (2016) (32)
- Whole-genome sequencing reveals clinically relevant insights into the aetiology of familial breast cancers (2019) (32)
- Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study (2014) (31)
- Evidence for SMAD3 as a modifier of breast cancer risk in BRCA2 mutation carriers (2010) (31)
- Morphology and genomic hallmarks of breast tumours developed by ATM deleterious variant carriers (2018) (31)
- Genome-wide Analysis Identifies Novel Loci Associated with Ovarian Cancer Outcomes: Findings from the Ovarian Cancer Association Consortium (2015) (31)
- A Mendelian randomization analysis of circulating lipid traits and breast cancer risk. (2019) (31)
- Association of PHB 1630 C>T and MTHFR 677 C>T polymorphisms with breast and ovarian cancer risk in BRCA1/2 mutation carriers: results from a multicenter study (2012) (31)
- Common germline polymorphisms associated with breast cancer-specific survival (2015) (31)
- Association of the SS genotype of the L-myc gene and loss of 18q sequences with a worse clinical prognosis in colorectal cancers. (1994) (31)
- Common Polymorphisms in ERCC2 (Xeroderma pigmentosum D) are not Associated with Breast Cancer Risk (2005) (30)
- Guidelines for whole genome bisulphite sequencing of intact and FFPET DNA on the Illumina HiSeq X Ten (2018) (30)
- Glutathione S-transferase GSTM1 null genotype is not overrepresented in Australian patients with nevoid basal cell carcinoma syndrome or sporadic melanoma. (1995) (30)
- An Alu VpA Marker on chromosome 1 demonstrates that replication errors manifest at the adenoma‐carcinoma transition in sporadic colorectal tumors (1995) (29)
- Increased expression of the nme1 gene is associated with metastasis in epithelial ovarian cancer (1995) (29)
- Genetic Data from Nearly 63,000 Women of European Descent Predicts DNA Methylation Biomarkers and Epithelial Ovarian Cancer Risk. (2018) (29)
- Reduced expression of chemokine (C-C motif) ligand-2 (CCL2) in ovarian adenocarcinoma (2005) (29)
- Candidate Genetic Modifiers for Breast and Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers (2014) (29)
- Whole-genome sequencing reveals clinically relevant insights into the aetiology of familial breast cancers. (2019) (28)
- The prevalence of cervical and thoracic congenital skeletal abnormalities in basal cell naevus syndrome; a review of cervical and chest radiographs in 80 patients with BCNS. (1995) (28)
- Using the MCF10A/MCF10CA1a Breast Cancer Progression Cell Line Model to Investigate the Effect of Active, Mutant Forms of EGFR in Breast Cancer Development and Treatment Using Gefitinib (2015) (28)
- The AIB1 Polyglutamine Repeat Does Not Modify Breast Cancer Risk in BRCA1 and BRCA2 Mutation Carriers (2006) (28)
- No evidence for microsatellite instability from allelotype analysis of benign and low malignant potential ovarian neoplasms. (1998) (28)
- Evaluation of a candidate breast cancer associated SNP in ERCC4 as a risk modifier in BRCA1 and BRCA2 mutation carriers. Results from the Consortium of Investigators of Modifiers of BRCA1/BRCA2 (CIMBA) (2009) (28)
- The progesterone receptor exon 4 Val660Leu G/T polymorphism and risk of breast cancer in Australian women. (2002) (28)
- Prohibitin 3′ untranslated region polymorphism and breast cancer risk in Australian women (2002) (27)
- A network analysis to identify mediators of germline-driven differences in breast cancer prognosis (2020) (27)
- Breast Cancer Polygenic Risk Score and Contralateral Breast Cancer Risk. (2020) (27)
- Development and Validation of the Gene Expression Predictor of High-grade Serous Ovarian Carcinoma Molecular SubTYPE (PrOTYPE) (2020) (27)
- Genetic variation in insulin-like growth factor 2 may play a role in ovarian cancer risk. (2011) (27)
- Fine scale mapping of the 17q22 breast cancer locus using dense SNPs, genotyped within the Collaborative Oncological Gene-Environment Study (COGs) (2016) (27)
- Growing recognition of the role for rare missense substitutions in breast cancer susceptibility. (2014) (27)
- Pathology of Tumors Associated With Pathogenic Germline Variants in 9 Breast Cancer Susceptibility Genes (2022) (27)
- Genetically predicted levels of DNA methylation biomarkers and breast cancer risk: data from 228,951 women of European descent. (2019) (27)
- Role of genetic polymorphisms in ovarian cancer susceptibility: development of an international ovarian cancer association consortium. (2008) (26)
- Homozygous deletions on the short arm of chromosome 9 in ovarian adenocarcinoma cell lines and loss of heterozygosity in sporadic tumors. (1994) (26)
- Expression of β-Catenin, a Key Mediator of the WNT Signaling Pathway, in Basal Cell Carcinoma (2000) (25)
- Evaluation of copy-number variants as modifiers of breast and ovarian cancer risk for BRCA1 pathogenic variant carriers (2017) (25)
- An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers (2015) (25)
- The spectrum of BRCA1 and BRCA2 pathogenic sequence variants in Middle Eastern, North African, and South European countries (2019) (25)
- The TP53 Arg72Pro and MDM2 309G>T polymorphisms are not associated with breast cancer risk in BRCA1 and BRCA2 mutation carriers (2009) (25)
- Fine-Scale Mapping of the 4q24 Locus Identifies Two Independent Loci Associated with Breast Cancer Risk (2015) (25)
- The effects of splice site mutations in patients with naevoid basal cell carcinoma syndrome (1998) (25)
- Regressive logistic and proportional hazards disease models for within‐family analyses of measured genotypes, with application to a CYP17 polymorphism and breast cancer (2003) (25)
- Polymorphism in the GALNT1 Gene and Epithelial Ovarian Cancer in Non-Hispanic White Women: The Ovarian Cancer Association Consortium (2010) (25)
- Progesterone receptor gene polymorphisms and risk of endometriosis: results from an international collaborative effort. (2011) (25)
- Exclusion of APC and MCC as the gene defect in one family with familial juvenile polyposis. (1993) (25)
- Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA (2013) (24)
- 9q31.2-rs865686 as a Susceptibility Locus for Estrogen Receptor-Positive Breast Cancer: Evidence from the Breast Cancer Association Consortium (2012) (24)
- The spectrum of patched mutations in a collection of Australian basal cell carcinomas (2000) (24)
- The diagnostic implication of falcine calcification on plain skull radiographs of patients with basal cell naevus syndrome and the incidence of falcine calcification in their relatives and two control groups. (1995) (24)
- Cep55 regulates embryonic growth and development by promoting Akt stability in zebrafish (2015) (24)
- Translating Germline Cancer Risk into Precision Prevention (2017) (24)
- Estrogen Receptor Beta rs1271572 Polymorphism and Invasive Ovarian Carcinoma Risk: Pooled Analysis within the Ovarian Cancer Association Consortium (2011) (24)
- Atopy in Australia (1995) (24)
- Evaluating the repair of DNA derived from formalin-fixed paraffin-embedded tissues prior to genomic profiling by SNP–CGH analysis (2013) (24)
- Mixed ductal‐lobular carcinomas: evidence for progression from ductal to lobular morphology (2018) (23)
- The BARD1 Cys557Ser polymorphism and breast cancer risk: an Australian case–control and family analysis (2009) (23)
- Analysis of RAD51C germline mutations in high-risk breast and ovarian cancer families and ovarian cancer patients (2012) (23)
- Paclitaxel sensitivity in relation to ABCB1 expression, efflux and single nucleotide polymorphisms in ovarian cancer (2014) (23)
- Genetic modifiers of menopausal hormone replacement therapy and breast cancer risk: a genome-wide interaction study. (2013) (23)
- Effects of BRCA2 cis-regulation in normal breast and cancer risk amongst BRCA2 mutation carriers (2012) (23)
- Association of ESR 1 gene tagging SNPs with breast cancer risk (2009) (23)
- LobSig is a multigene predictor of outcome in invasive lobular carcinoma (2019) (22)
- BRCA1 and BRCA2 pathogenic sequence variants in women of African origin or ancestry (2019) (22)
- Chromatin interactome mapping at 139 independent breast cancer risk signals (2019) (22)
- Genome-wide association studies identify susceptibility loci for epithelial ovarian cancer in east Asian women. (2019) (22)
- FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium (2014) (22)
- Analysis of Over 10,000 Cases Finds No Association between Previously Reported Candidate Polymorphisms and Ovarian Cancer Outcome (2013) (22)
- Assessing the genetic architecture of epithelial ovarian cancer histological subtypes (2016) (22)
- The steroid 5alpha-reductase type II TA repeat polymorphism is not associated with risk of breast or ovarian cancer in Australian women. (2001) (22)
- Population-based targeted sequencing of 54 candidate genes identifies PALB2 as a susceptibility gene for high-grade serous ovarian cancer (2019) (22)
- Genetic Variation in TYMS in the One-Carbon Transfer Pathway Is Associated with Ovarian Carcinoma Types in the Ovarian Cancer Association Consortium (2010) (22)
- A Nonsynonymous Polymorphism in IRS1 Modifies Risk of Developing Breast and Ovarian Cancers in BRCA1 and Ovarian Cancer in BRCA2 Mutation Carriers (2012) (22)
- Evidence for microsatellite instability in bilateral breast carcinomas. (2000) (21)
- Meta-analysis of the global gene expression profile of triple-negative breast cancer identifies genes for the prognostication and treatment of aggressive breast cancer (2014) (21)
- Analysis of the TGFβ functional pathway in epithelial ovarian carcinoma (2001) (21)
- MyD88 and TLR4 Expression in Epithelial Ovarian Cancer (2018) (21)
- Exploring the link between MORF4L1 and risk of breast cancer (2011) (21)
- The intronic G13964C variant in p53 is not a high-risk mutation in familial breast cancer in Australia (2001) (21)
- eQTL Colocalization Analyses Identify NTN4 as a Candidate Breast Cancer Risk Gene. (2020) (21)
- Polymorphism in the IL18 Gene and Epithelial Ovarian Cancer in Non-Hispanic White Women (2008) (21)
- The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer (2019) (20)
- Large-Scale Evaluation of Common Variation in Regulatory T Cell–Related Genes and Ovarian Cancer Outcome (2014) (20)
- Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy (2015) (20)
- Mutation analysis of five candidate genes in familial breast cancer (2006) (20)
- Multidimensional phenotyping of breast cancer cell lines to guide preclinical research (2017) (20)
- No evidence for association of ataxia-telangiectasia mutated gene T2119C and C3161G amino acid substitution variants with risk of breast cancer (2002) (20)
- Association of breast cancer risk in BRCA1 and BRCA2 mutation carriers with genetic variants showing differential allelic expression: identification of a modifier of breast cancer risk at locus 11q22.3 (2016) (20)
- Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry (2016) (20)
- The prohibitin 3' untranslated region polymorphism is not associated with risk of ovarian cancer. (2003) (19)
- Haplotype structure in Ashkenazi Jewish BRCA1 and BRCA2 mutation carriers (2011) (19)
- Restriction fragment length polymorphisms of L-myc and myb in human leukaemia and lymphoma in relation to age-selected controls. (1989) (19)
- 2q36.3 is associated with prognosis for oestrogen receptor-negative breast cancer patients treated with chemotherapy (2014) (19)
- Is Schizophrenia a Risk Factor for Breast Cancer?-Evidence From Genetic Data. (2018) (19)
- RNF168 regulates R-loop resolution and genomic stability in BRCA1/2-deficient tumors. (2021) (18)
- Functional Analysis and Fine Mapping of the 9p22.2 Ovarian Cancer Susceptibility Locus. (2018) (18)
- No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. (2016) (18)
- The BRCA2 c.68‐7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity (2018) (18)
- No evidence for an association between the earwax-associated polymorphism in ABCC11 and breast cancer risk in Caucasian women (2011) (18)
- Germline deletion of ETV6 in familial acute lymphoblastic leukemia. (2019) (18)
- Evaluating the ovarian cancer gonadotropin hypothesis: a candidate gene study. (2015) (17)
- Apparent protection from instability of repeat sequences in cancer-related genes in replication error positive gastrointestinal cancers (1997) (17)
- Sodium butyrate differentially modulates plasminogen activator inhibitor type-1, urokinase plasminogen activator, and its receptor in a human colon carcinoma cell. (1993) (17)
- The MnSOD Val9Ala polymorphism, dietary antioxidant intake, risk and survival in ovarian cancer (Australia). (2007) (17)
- Assignment1 of the human slit homologue SLIT2 to human chromosome band 4p15.2 (1999) (17)
- Correction: Common Genetic Variants and Modification of Penetrance of BRCA2-Associated Breast Cancer (2010) (17)
- Height and Body Mass Index as Modifiers of Breast Cancer Risk in BRCA1/2 Mutation Carriers: A Mendelian Randomization Study. (2018) (17)
- Characterization of the breast cancer associated ATM 7271T>G (V2424G) mutation by gene expression profiling (2006) (17)
- Non-coding RNAs underlie genetic predisposition to breast cancer (2020) (17)
- A protein‐truncating mutation in CYP17A1 in three sisters with early‐onset breast cancer (2005) (16)
- BRCA1 and BRCA2 Missense Variants of High and Low Clinical Significance Influence Lymphoblastoid Cell Line Post-Irradiation Gene Expression (2008) (16)
- Transcriptome-wide association study of breast cancer risk by estrogen-receptor status (2020) (16)
- Common variants at 12p11, 12q24, 9p21, 9q31.2 and in ZNF365 are associated with breast cancer risk for BRCA1 and/or BRCA2mutation carriers (2012) (16)
- Somatic rearrangement of the c‐myc oncogene in primary human diffuse large‐cell lymphoma (1986) (16)
- Altered regulation of c-myc in an HL-60 differentiation resistant subclone, HL-60-1E3. (1987) (16)
- Common Genetic Variation at BARD1 Is Not Associated with Breast Cancer Risk in BRCA1 or BRCA2 Mutation Carriers (2011) (16)
- Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses (2020) (15)
- UKCCCR guidelines for the use of cell lines in cancer research (1999) (15)
- Mendelian randomisation study of height and body mass index as modifiers of ovarian cancer risk in 22,588 BRCA1 and BRCA2 mutation carriers (2019) (15)
- A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (2021) (15)
- What makes a good PhD student? (2006) (15)
- The SNP rs6500843 in 16p13.3 is associated with survival specifically among chemotherapy-treated breast cancer patients (2015) (15)
- SNPs in lncRNA Regions and Breast Cancer Risk (2020) (15)
- Refined cut-off for TP53 immunohistochemistry improves prediction of TP53 mutation status in ovarian mucinous tumors: implications for outcome analyses (2020) (15)
- Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer. (2015) (14)
- Assessment of moderate coffee consumption and risk of epithelial ovarian cancer: a Mendelian randomization study. (2018) (14)
- Common Genetic Variants and Modification of Penetrance of BRCA 2-Associated Breast Cancer (2010) (14)
- Current research and treatment for epithelial ovarian cancer. A Position Paper from the Helene Harris Memorial Trust. (2003) (14)
- Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus (2016) (14)
- Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade. (2014) (14)
- Ovarian cancer survival and polymorphisms in hormone and DNA repair pathway genes. (2007) (14)
- Breast Cancer Risk and 6q22.33: Combined Results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2 (2012) (14)
- Risk factors for symptomatic venous thromboembolism during therapy for childhood acute lymphoblastic leukemia. (2019) (14)
- No evidence that CDKN1B (p27) polymorphisms modify breast cancer risk in BRCA1 and BRCA2 mutation carriers (2009) (13)
- "I am not a statistic" ovarian cancer survivors' views of factors that influenced their long-term survival. (2019) (13)
- No evidence that GATA3 rs570613 SNP modifies breast cancer risk (2009) (13)
- HER 3 and downstream pathways are involved in colonization of brain metastases from breast cancer (2010) (13)
- No association of TGFB1 L10P genotypes and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a multi-center cohort study (2009) (13)
- Expression of beta-catenin, a key mediator of the WNT signaling pathway, in basal cell carcinoma. (2000) (13)
- Validating genetic risk associations for ovarian cancer through the international Ovarian Cancer Association Consortium (2009) (13)
- Evaluation of the XRCC1 gene as a phenotypic modifier in BRCA1/2 mutation carriers. Results from the consortium of investigators of modifiers of BRCA1/BRCA2 (2011) (13)
- The human growth-arrest-specific gene GAS1 maps outside the candidate region of the gene for nevoid basal cell carcinoma syndrome. (1995) (12)
- UV induction of transforming growth factor alpha in melanoma cell lines is a posttranslational event (1992) (12)
- Mutation analysis of RAD51L1 (RAD51B/REC2) in multiple-case, non-BRCA1/2 breast cancer families (2011) (12)
- Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study (2018) (12)
- No germline mutations in the histone acetyltransferase gene EP300 in BRCA1 and BRCA2 negative families with breast cancer and gastric, pancreatic, or colorectal cancer (2004) (12)
- Menopausal hormone therapy prior to the diagnosis of ovarian cancer is associated with improved survival. (2020) (12)
- Pooled analysis indicates that the GSTT1 deletion, GSTM1 deletion, and GSTP1 Ile105Val polymorphisms do not modify breast cancer risk in BRCA1 and BRCA2 mutation carriers (2010) (11)
- Polygenic risk modeling for prediction of epithelial ovarian cancer risk (2022) (11)
- Are estrogen receptor-positive breast cancers in BRCA1 mutation carriers sporadic? (2010) (11)
- A comprehensive gene–environment interaction analysis in Ovarian Cancer using genome‐wide significant common variants (2019) (11)
- Exome genotyping arrays to identify rare and low frequency variants associated with epithelial ovarian cancer risk. (2016) (11)
- Spastic paresis, glaucoma and mental retardation ‐ a probable autosomal recessive syndrome? (1986) (11)
- BCoR-L1 variation and breast cancer (2007) (11)
- Analysis of the transcription regulator, CNOT7, as a candidate chromosome 8 tumor suppressor gene in colorectal cancer (2003) (11)
- Single Nucleotide Polymorphisms in the TP 53 Region and Susceptibility to Invasive Epithelial Ovarian Cancer (2009) (11)
- Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility: results from a large-scale collaboration (2016) (10)
- AURKA F 31 I Polymorphism and Breast Cancer Risk in BRCA 1 and BRCA 2 Mutation Carriers : A Consortium of Investigators of Modifiers of BRCA 1 / 2 Study (2007) (10)
- The KL-VS sequence variant of Klotho and cancer risk in BRCA1 and BRCA2 mutation carriers (2012) (10)
- Methotrexate-related central neurotoxicity: clinical characteristics, risk factors and genome-wide association study in children treated for acute lymphoblastic leukemia (2021) (10)
- High content screening application for cell-type specific behaviour in heterogeneous primary breast epithelial subpopulations (2016) (10)
- Parent-of-origin-specific allelic associations among 106 genomic loci for age at menarche DTU Orbit (05/11/2017) (2014) (10)
- TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer (2017) (10)
- The predictive ability of the 313 variant–based polygenic risk score for contralateral breast cancer risk prediction in women of European ancestry with a heterozygous BRCA1 or BRCA2 pathogenic variant (2021) (10)
- Chromosome analysis of 30 cases of non-Hodgkin’s lymphoma (1988) (10)
- Breast and Prostate Cancer Risks for Male BRCA1 and BRCA2 Pathogenic Variant Carriers Using Polygenic Risk Scores (2021) (9)
- Transfer of chromosome 8 into two breast cancer cell lines: total exclusion of three regions indicates location of putative in vitro growth suppressor genes. (2003) (9)
- Genome-Wide Association Study for Ovarian Cancer Susceptibility Using Pooled DNA (2012) (9)
- Panel sequencing of 264 candidate susceptibility genes and segregation analysis in a cohort of non-BRCA1, non-BRCA2 breast cancer families (2017) (9)
- Fine-mapping of 150 breast cancer risk regions identifies 178 high confidence target genes (2019) (9)
- Estimating single nucleotide polymorphism associations using pedigree data: applications to breast cancer (2013) (9)
- Lymphoblastoid cell lines from frozen whole blood: a quick and economical safeguard for linkage analysis. (1990) (9)
- Polymorphisms in Stromal Genes and Susceptibility to Serous Epithelial Ovarian Cancer: A Report from the Ovarian Cancer Association Consortium (2011) (9)
- Ovarian cancer risk, ALDH2 polymorphism and alcohol drinking: Asian data from the Ovarian Cancer Association Consortium (2018) (9)
- Variants in genes encoding small GTPases and association with epithelial ovarian cancer susceptibility (2018) (9)
- Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in BRCA1 and BRCA2 Mutation Carriers (2016) (9)
- Polymorphisms in the FGF2 Gene and Risk of Serous Ovarian Cancer: Results From the Ovarian Cancer Association Consortium (2009) (9)
- Functional dissection of breast cancer risk-associated TERT promoter variants (2017) (8)
- Ratio of male to female births in the offspring of BRCA1 and BRCA2 carriers (2005) (8)
- Germ-line variation at a functional p53 binding site increases susceptibility to breast cancer development (2009) (8)
- Corrigendum: The genomic landscape of juvenile myelomonocytic leukemia (2015) (8)
- Exploring the link between MORF4L1 and risk of breast cancer (2011) (8)
- Prediction of BRCA1 and BRCA2 mutation status using post-irradiation assays of lymphoblastoid cell lines is compromised by inter-cell-line phenotypic variability (2007) (8)
- Functional dissection of breast cancer risk-associated TERT promoter variants. (2017) (8)
- Localization of the gene for human proliferating nuclear antigen/cyclin by in situ hybridization (1990) (8)
- RAD52 Y415X truncation polymorphism and epithelial ovarian cancer risk in Australian women. (2005) (7)
- Evaluating the role of alcohol consumption in breast and ovarian cancer susceptibility using population‐based cohort studies and two‐sample Mendelian randomization analyses (2020) (7)
- The molecular genetics of human non-Hodgkin's lymphoma. (1987) (7)
- A BRCA1 promoter variant (rs11655505) and breast cancer risk (2010) (7)
- The application of nonsense-mediated mRNA decay inhibition to the identification of breast cancer susceptibility genes (2012) (7)
- A splicing variant of TERT identified by GWAS interacts with menopausal estrogen therapy in risk of ovarian cancer (2016) (7)
- Risks of breast and ovarian cancer for women harboring pathogenic missense variants in BRCA1 and BRCA2 compared with those harboring protein truncating variants. (2022) (7)
- CYP 17 PROMOTOR POLYMORPHISM AND OVARIAN CANCER RISK (2000) (7)
- BRAF polymorphisms and the risk of ovarian cancer of low malignant potential. (2005) (7)
- Sequence variants of DLC1 in colorectal ovarian tumours (2000) (7)
- Common variants in breast cancer risk loci predispose to distinct tumor subtypes (2022) (6)
- Breast cancer risks associated with missense variants in breast cancer susceptibility genes (2021) (6)
- A Single Nucleotide Polymorphism in the 5 Untranslated Region of RAD 51 and Risk of Cancer among BRCA 1 / 2 Mutation Carriers 1 (2001) (6)
- Evaluation of chromosome 6p22 as a breast cancer risk modifier locus in a follow-up study of BRCA2 mutation carriers (2012) (6)
- Integration of Population-Level Genotype Data with Functional Annotation Reveals Over-Representation of Long Noncoding RNAs at Ovarian Cancer Susceptibility Loci (2016) (6)
- Evaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer risk (2011) (6)
- Candidate Causal Variants at the 8p12 Breast Cancer Risk Locus Regulate DUSP4 (2019) (6)
- High-throughput allelic expression imbalance analyses identify candidate breast cancer risk genes (2019) (6)
- Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation (2018) (6)
- The AIB 1 Polyglutamine Repeat Does Not Modify Breast Cancer Risk in BRCA 1 and BRCA 2 Mutation Carriers (2006) (6)
- Combining genome-wide studies of breast, prostate, ovarian and endometrial cancers maps cross-cancer susceptibility loci and identifies new genetic associations (2020) (6)
- Functional annotation of the 2q35 breast cancer risk locus implicates a structural variant in influencing activity of a long-range enhancer element (2021) (6)
- Epigenome erosion and SOX10 drive neural crest phenotypic mimicry in triple-negative breast cancer (2022) (6)
- 7q21-rs6964587 and breast cancer risk: an extended case–control study by the Breast Cancer Association Consortium (2011) (6)
- Common breast cancer risk loci predispose to distinct tumor subtypes (2019) (6)
- Genome-Wide Association Meta-Analysis of Single-Nucleotide Polymorphisms and Symptomatic Venous Thromboembolism during Therapy for Acute Lymphoblastic Leukemia and Lymphoma in Caucasian Children (2020) (6)
- Pleiotropy-guided transcriptome imputation from normal and tumor tissues identifies candidate susceptibility genes for breast and ovarian cancer (2020) (5)
- Erratum: Corrigendum: A common coding variant in CASP8 is associated with breast cancer risk (2007) (5)
- Evidence for SMAD 3 as a modifier of breast cancer risk in BRCA 2 mutation carriers (2010) (5)
- The use of the Illumina FFPE Restoration Protocol to obtain suitable quality DNA for SNP-based CGH– a pilot study (2012) (5)
- Application of molecular findings to the diagnosis and management of breast disease: recent advances and challenges. (2011) (5)
- CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers (2021) (5)
- BamHI RFLP of the inhibin beta B (INHBB) chain gene on chromosome 2. (1990) (5)
- Correction: Common Genetic Variants and Modification of Penetrance of BRCA2-Associated Breast Cancer (2010) (5)
- Expression of p 53 in Arsenic-Related and Sporadic Basal Cell Carcinoma (2000) (5)
- The EcoRI rflp of c‐MOS in patients with non‐Hodgkin's lymphoma and acute lymphoblastic leukemia, compared to geriatric and non‐Geriatric controls (1989) (4)
- Publisher Correction: Shared heritability and functional enrichment across six solid cancers (2019) (4)
- RESPONSE: Re: Dominant Negative ATM Mutations in Breast Cancer Families (2002) (4)
- Correction: Corrigendum: Common variants at 19p13 are associated with susceptibility to ovarian cancer (2016) (4)
- Chromosome 8 genetic analysis and phenotypic characterization of 21 ovarian cancer cell lines. (2002) (4)
- Cytogenetic and molecular genetic studies of a patient with atypical lymphoid hyperplasia. (1987) (4)
- Characterization of a novel breast cancer cell line derived from a metastatic bone lesion of a breast cancer patient (2018) (4)
- Abstract 162: DNA methylome in familial breast cancer identifies distinct profiles defined by mutation status (2010) (4)
- rs495139 in the TYMS-ENOSF1 Region and Risk of Ovarian Carcinoma of Mucinous Histology (2018) (4)
- Correction: Comparison of 6q25 Breast Cancer Hits from Asian and European Genome Wide Association Studies in the Breast Cancer Association Consortium (BCAC) (2012) (4)
- No Evidence That Genetic Variation in the Myeloid-Derived Suppressor Cell Pathway Influences Ovarian Cancer Survival (2016) (3)
- Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment (2021) (3)
- The CYP17A1 −34T > C polymorphism and breast cancer risk in BRCA1 and BRCA2 mutation carriers (2011) (3)
- Mutation and expression analysis of LZTS1 in ovarian cancer. (2006) (3)
- Abstract 2598: Predicting breast and ovarian cancer risks for BRCA1 and BRCA2 mutation carriers using polygenic risk scores (2016) (3)
- Analyses of germline variants associated with ovarian cancer survival identify functional candidates at the 1q22 and 19p12 outcome loci. (2017) (3)
- Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with risk of clear cell ovarian cancer (2016) (3)
- Mendelian randomisation study of smoking exposure in relation to breast cancer risk (2021) (3)
- Association of germline variation with the survival of women with BRCA1/2 pathogenic variants and breast cancer. (2020) (3)
- Immune Cell Associations with Cancer Risk (2020) (3)
- Association of germline variation with the survival of women with BRCA1/2 pathogenic variants and breast cancer (2020) (3)
- Relationship Between Number of Ovulatory Cycles and Accumulation of Mutant p 53 in Epithelial Ovarian Cancer (1998) (2)
- Erratum: Validating genetic risk associations for ovarian cancer through the International Ovarian Cancer Association Consortium (British Journal of Cancer (2009) 100 (412-420) DOI: 10.1038/sj.bjc.6604820 www.bjcancer.com) (2009) (2)
- Association between KRAS rs61764370 and triple-negative breast cancer--a false positive? (2011) (2)
- More on Co-Occurrence of COMT and BRCA1/2 Variants in a Population. (2017) (2)
- Allelic variation of the c-raf-1 oncogene in non-Hodgkin's lymphoma. (1987) (2)
- Identification of a Locus Near ULK1 Associated With Progression-Free Survival in Ovarian Cancer (2021) (2)
- Analyses of germline variants associated with ovarian cancer survival identify functional candidates at the 1q22 and 19p12 outcome loci (2017) (2)
- rs2735383, located at a microRNA binding site in the 3’UTR of NBS1, is not associated with breast cancer risk (2016) (2)
- Functional polymorphisms in the TERT promoter are associated with risk of serious ovarian and breast cancer (2012) (2)
- NcoI RFLP of the human LHRH gene on chromosome 8p. (1991) (2)
- PstI RFLP of the CGB gene. (1990) (2)
- Genomic analyses for age at menarche identify 389 independent signals and indicate BMI-independent effects of puberty timing on cancer susceptibility (2016) (2)
- Annexin A 1 expression in a pooled breast cancer series (2)
- Reproductive profiles and risk of breast cancer subtypes: a multi-center case-only study (2017) (2)
- Association of KRAS SNP rs61764370 with risk of invasive epithelial ovarian cancer: Implications for clinical testing (2011) (1)
- Polygenic Risk Modelling for Prediction of Epithelial Ovarian Cancer Risk (2020) (1)
- A multi-center study to evaluate the impact of germline BRCA1 and BRCA2 mutations on ovarian cancer survival (2012) (1)
- Selected abstracts submitted to the Third International Symposium on Hereditary Breast and Ovarian Cancer (2009) (1)
- Rare germline copy number variants (CNVs) and breast cancer risk (2022) (1)
- Abstract 2854: Genetic variation in stromal genes decorin and lumican and susceptibility to serous ovarian cancer (2010) (1)
- Abstract 4727: TERT SNPs and ovarian cancer risk (2010) (1)
- MspI RFLP of FSHB on chromosome 11p. (1991) (1)
- LobSig is a multigene predictor of outcome in invasive lobular carcinoma (2019) (1)
- Simple repeat polymorphism at the D9S151 locus. (1994) (1)
- Fine-Scale Mapping at 9p22.2 Identifies Candidate Causal Variants That Modify Ovarian Cancer Risk in $\small \textit{BRCA1}$ and $\small \textit{BRCA2}$ Mutation Carriers (2016) (1)
- Common variants at the CHEK2 gene locus and risk of epithelial ovarian cancer. (2015) (1)
- Urokinase receptor genotypes in colorectal cancer. (1998) (1)
- University of Groningen Evaluation of Polygenic Risk Scores for Breast and Ovarian Cancer Risk Prediction in BRCA 1 and BRCA 2 Mutation Carriers (2017) (1)
- A gene expression prognostic signature for overall survival in patients with high-grade serous ovarian cancer. (2018) (1)
- What's in a cancer syndrome? Genes, phenotype and pathology (2008) (1)
- Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer (2016) (1)
- BcII RFLP of the plasminogen activator inhibitor type 2 gene (PLANH) on chromosome 18q21-q23. (1990) (1)
- TP 53-based interaction analysis identifies cis-eQTL variants for TP 53 BP 2 , FBXO 28 , and FAM 53 A that associate with survival and treatment outcome in breast cancer (2017) (1)
- Breast Cancer Risk Modifiers (2007) (1)
- Primary treatment patterns in women recruited to the Australian Ovarian Cancer Study (2012) (1)
- Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study (2014) (1)
- Reproductive hormone genes in mothers of spontaneous dizygotic twins: an association study (1993) (1)
- Abstract 2752: Genetic heterogeneity of ovarian cancer survival effects inBRCA1/2germline mutations: a large, multi-center study (2011) (1)
- Non-coding RNAs underlie genetic predisposition to breast cancer (2020) (1)
- Heritable DNA methylation marks associated with susceptibility to breast cancer (2018) (1)
- Journal size increases to four volumes per year Editorial Board additions (1995) (1)
- Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy (2015) (1)
- Correction: Polygenic risk modeling for prediction of epithelial ovarian cancer risk (2022) (1)
- Abstract 3875: NUAK2, a gene with a putative driver mutation in ovarian cancer, is regulated through the murine estrus cycle and loss is associated with worse outcome in ovarian cancer (2011) (1)
- Inheritance of deleterious mutations at both BRCA1 and BRCA2 in an international sample of 32,295 women (2016) (1)
- Common Polymorphisms in ERCC 2 ( Xeroderma pigmentosum D ) are not Associated with Breast Cancer Risk (2005) (1)
- A network analysis to identify mediators of germline-driven differences in breast cancer prognosis (2020) (1)
- 027. Mapping novel breast cancer susceptibility genes by linkage analysis of Australian multiple case kindreds (2004) (1)
- TRACEBACK: Testing of Historical Tubo-Ovarian Cancer Patients for Hereditary Risk Genes as a Cancer Prevention Strategy in Family Members (2022) (1)
- Copy number variants as modifiers of breast cancer risk for BRCA1/BRCA2 pathogenic variant carriers (2022) (1)
- Effects of BRCA2 cis-regulation in normal breast and cancer risk amongst BRCA2 mutation carriers (2012) (1)
- COMPLEXO: identifying the missing heritability of breast cancer via next generation collaboration (2013) (1)
- Genetic predisposition to ductal carcinoma in situ of the breast (2016) (1)
- Identification of new breast cancer predisposition genes via whole exome sequencing (2012) (1)
- Null Results in Brief Common Genetic Variation at BARD 1 Is Not Associated with Breast Cancer Risk in BRCA 1 or BRCA 2 Mutation Carriers (2011) (1)
- Exclusion of APC and MCC as the With Familial Juvenile Polyposis Gene Defect in One Family (1993) (1)
- Uncovering molecular mechanisms involved in metastasis to the brain (2012) (1)
- Abstract 2761: Germline polymorphism discovered via a cell-based genome-wide approach predicts platinum response in ovarian and head and neck cancers (2010) (1)
- KRAS variant rs61764370 is not associated with ovarian cancer risk or survival in the Ovarian Cancer Association Consortium (OCAC) or Consortium of Modifiers of BRCA1 and BRCA2 (CIMBA) (2015) (1)
- Adult height is associated with increased risk of ovarian cancer: a Mendelian randomisation study (2018) (1)
- Corrigendum: A common coding variant in CASP8 is associated with breast cancer risk (2007) (1)
- Breast Cancer Risk and 6 q 22 . 33 : Combined Results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA 1 / 2 (2012) (1)
- Prostate Cancer Susceptibility Polymorphism rs2660753 Is Not Associated with Invasive Ovarian Cancer (2011) (1)
- Copy Number Variation and Ovarian Cancer Risk—Letter (2020) (1)
- Methylation of all BRCA1 copies predicts response to the PARP inhibitor rucaparib in ovarian carcinoma (2018) (1)
- Genetic and immunohistopathological evaluation of BRCA1 and BRCA2 unclassified variants (2005) (0)
- Linkage and Loss of Heterozygosity (2006) (0)
- The importance of using public data to validate reported associations (2018) (0)
- Associations of common breast cancer susceptibility alleles with risk of breast cancer subtypes in BRCA1 and BRCA2 mutation carriers (2014) (0)
- Basal cell naevus syndrome (1992) (0)
- Polygenic risk modeling for prediction of epithelial ovarian cancer risk (2022) (0)
- Searching for BRCA3 by exome sequencing (2012) (0)
- A multi-center study to evaluate the impact of germline BRCA1 and BRCA2 mutations on ovarian cancer survival (2012) (0)
- Genome-wide association study for identification of candidate SNPs associated with carboplatin and paclitaxel clearance in ovarian cancer patients. (2014) (0)
- Sporadic Tumors (2007) (0)
- Abstract 4633: Evidence that long non-coding RNA variants associate with epithelial ovarian cancer risk (2015) (0)
- Abstract 2211: Patient level polygenic risk scores and continuous estrogen receptor expression in breast cancer (2018) (0)
- Genomic and transcriptomic landscapes of human brain metastases (2015) (0)
- Functional analysis of TERT locus polymorphisms which are associated with risk of breast and ovarian cancer (2012) (0)
- The impact of coding germline variants on contralateral breast cancer risk and survival (2023) (0)
- The use of the Illumina FFPE Restoration Protocol to obtain suitable quality DNA for SNP-based CGH– a pilot study (2012) (0)
- The challenges of finding the gene responsible for a rare, autosomal dominant gastric cancer susceptibility syndrome (2012) (0)
- Abstract P5-10-01: Using whole genome sequencing and somatic mutation signatures to unravel insight into familial breast cancer aetiology (2019) (0)
- The E-cadherin-catenin system in ovarian cancer (1999) (0)
- Functional polymorphisms in the TERT promoter are associated with risk of serious ovarian and breast cancer (2012) (0)
- SNP rs2180341 per-allele hazard ratios (HRs) and 95% confidence intervals (CIs) among Consortium of Investigators of Modifiers of BRCA1/2 (CIMBA) in A. BRCA1 mutation carriers B. BRCA2 mutation carriers. (2012) (0)
- Genetic Modifiers of Risk of BRCA1 - and BRCA2 -Related Breast and Ovarian Cancers (2009) (0)
- An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers (2015) (0)
- Genome-wide association study of subtype-specific epithelial ovarian cancer risk alleles using pooled DNA (2013) (0)
- Two ATM variants, IVS10-6T>G and 1420L>F, and breast cancer risk (2005) (0)
- Abstract P2-03-01: Mutational landscape of breast cancers from PALB2 germline mutation carriers (2016) (0)
- Abstract PD1-15: The landscape of somatic genetic alterations in breast cancers fromATMgermline mutation carriers (2018) (0)
- Role of HER3 in brain metastases from primary breast cancer (2012) (0)
- Abstract A55: Influence of ABCB1 polymorphisms on paclitaxel pharmacokinetics in ovarian cancer patients (2013) (0)
- FANCM missense variants and breast cancer risk: a case-control association study of 75,156 European women. (2023) (0)
- Germline variants and breast cancer survival in patients with distant metastases at primary breast cancer diagnosis (2021) (0)
- The potential of Senicapoc, a KCNN4 inhibitor, for the prevention and treatment of breast cancer (2023) (0)
- CRISPR screens identify gene targets and drug repositioning opportunities at breast cancer risk loci (2021) (0)
- Shared heritability and functional enrichment across six solid cancers (2019) (0)
- MostGerm-Line Mutations intheNevoidBasal CellCarcinoma Syndrome Leadtoa Premature Termination ofthePATCHEDProtein, andNoGenotype-Phenotype Correlations AreEvident (1997) (0)
- Breast cancer risks associated with missense variants in breast cancer susceptibility genes (2022) (0)
- Identification of a genetic variant associated with treatment outcome in ovarian cancer: the potential role of cholesterol metabolism as a determinant of response to chemotherapy (2012) (0)
- Common germline polymorphisms associated with breast cancer-specific survival (2015) (0)
- Common variants in breast cancer risk loci predispose to distinct tumor subtypes (2022) (0)
- Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2. (2023) (0)
- A preliminary model for the development of sporadic serous ovarian adenocarcinoma (1994) (0)
- Common variants in breast cancer risk loci predispose to distinct tumor subtypes (2022) (0)
- Chromatin interactome mapping at 139 independent breast cancer risk signals (2020) (0)
- Common genomic variants associated with breast cancer predict the risk of second primary breast cancer diagnosis (2012) (0)
- Molecular Epidemiology of Ovarian Cancer (2004) (0)
- A fine-scale dissection of the DNA double-strand break repair machinery and its implications for breast cancer therapy (2014) (0)
- A short ERK5 isoform modulates nucleocytoplasmic shuttling of active ERK5 and associates with poor survival in breast cancer (2021) (0)
- CRISPR screens identify gene targets at breast cancer risk loci (2023) (0)
- Evolutionary conservation analysis may help identify functional exonic splice enhancer motifs in BRCA1 and BRCA2 (2005) (0)
- The application of nonsense-mediated mRNA decay inhibition to the identification of breast cancer susceptibility genes (2012) (0)
- Abstract 3451: Breast cancer risk factor associations by loss of E-cadherin tumor tissue expression: A pooled analysis of 5,896 cases in 12 studies from the Breast Cancer Association Consortium (BCAC) (2016) (0)
- Correction: Polygenic risk modeling for prediction of epithelial ovarian cancer risk (2022) (0)
- Correction: BCoR-L1 variation and breast cancer (2008) (0)
- Molecular Characterization and Cancer Risk Associated with BRCA1 and BRCA2 Splice Site Variants Identified in Multiple‐Case Breast Cancer Families (2014) (0)
- Morphology and genomic hallmarks of breast tumours developed by ATM deleterious variant carriers (2018) (0)
- A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer (2018) (0)
- Correction: Polygenic risk modeling for prediction of epithelial ovarian cancer risk (2022) (0)
- Abstract 914: Xenobiotic metabolizing SNPs and ovarian cancer risk (2010) (0)
- Dr. John L. Hamerton steps-down from the Associate Editorship (1995) (0)
- Current research and treatment for epithelial ovarian cancer. A position paper from the Helene Harris Memorial Trust (vol 39, pg 1818, 2003) (2004) (0)
- Identification of new breast cancer predisposition genes via whole exome sequencing (2012) (0)
- Edinburgh Research Explorer TP53-based interaction analysis identifies cis-eQTL variants for TP53BP2, FBXO28, and FAM53A that associate with survival and treatment outcome in breast cancer (2018) (0)
- WGS and targetted sequencing in acute lymphoblastic leukemia identifies putative enhancer mutation associated with over‐expression of a growth factor (2015) (0)
- The association between Polygenic Risk Scores and contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers: Analyses in the CIMBA consortium (2018) (0)
- Correction: Polygenic risk modeling for prediction of epithelial ovarian cancer risk (2022) (0)
- Common genomic variants associated with breast cancer predict the risk of second primary breast cancer diagnosis (2012) (0)
- 770 GENERATION OF A GASTRIC ADENOCARCINOMA AND PROXIMAL POLYPOSIS OF THE STOMACH (GAPPS) MOUSE THAT PHENOCOPIES HUMAN DISEASE (2020) (0)
- Epigenome erosion drives neural crest-like phenotypic mimicry in triple-negative breast cancer and other SOX10+ malignancies (2021) (0)
- Searching for BRCA3 by exome sequencing (2012) (0)
- Assessing the genetic architecture of epithelial ovarian cancer histological subtypes (2016) (0)
- High content screening application for cell-type specific behaviour in heterogeneous primary breast epithelial subpopulations (2016) (0)
- Ovarian Cancer Control Genes and Susceptibility to Invasive Epithelial Tagging Single Nucleotide Polymorphisms in Cell Cycle (2007) (0)
- Abstract 4679: A multi-stage genome-wide association study on response to chemotherapy in ovarian cancer (2011) (0)
- A Novel Method to Screen for Dominant Negative ATM Mutations in Familial Breast Cancer (2005) (0)
- Association of rs12662670 with breast cancer in Asian ER (2012) (0)
- Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer (2019) (0)
- Erratum to “Current research and treatment for epithelial ovarian cancer. A Position Paper from the Helene Harris Memorial Trust” [European Journal of Cancer, 39 (2003) 1818–1827] (2004) (0)
- Common single nucleotide polymorphisms that increase ovarian cancer risk: Update from the Ovarian Cancer Association Consortium (2013) (0)
- The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer (2019) (0)
- Epidemiological Insights into Ovarian Carcinogenesis - the First Results from the Australian Ovarian Cancer Study (2006) (0)
- Abstract 946: Exome genotyping array identifies rare and low-frequency variants that may be associated with ovarian cancer risk (2014) (0)
- Author Correction: A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers (2021) (0)
- Subject Index Vol. 86, 1999 (1999) (0)
- Association of genetic susceptibility variants for type 2 diabetes with breast cancer risk in women of European ancestry (2016) (0)
- Copy Number Variants Are Ovarian Cancer Risk Alleles at Known and Novel Risk Loci (2022) (0)
- Abstract 2783: Common functional mechanisms underlying pleiotropy at the 19p13.1 breast and ovarian cancer cusceptibility locus (2015) (0)
- Refined histopathological predictors of BRCA1 and BRCA2 mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia | NOVA. The University of Newcastle's Digital Repository (2014) (0)
- Identification of potentially pathogenic variants in candidate breast and ovarian cancer susceptibility genes in BRCAX patients (2016) (0)
- Isolation of genes involved in colorectal metastasis by differential display of mRNA species (1994) (0)
- Fertility and incidence of KRAS2 mutations in borderline ovarian adenocarcinomas. (1997) (0)
- Genome-wide association study of germline variants and breast cancer-speci fi c mortality (2019) (0)
- Abstract 758: The clinical utility of BRCA1/2 pathogenic variants in breast cancer patient prognosis (2021) (0)
- Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses (2020) (0)
- q 31 . 2 and in ZNF 365 are associated with breast cancer risk for BRCA 1 and / or BRCA 2 mutation carriers (2012) (0)
- Genetically predicted DNA methylation biomarkers and epithelial ovarian cancer risk: data from nearly 63,000 women of European descent (2019) (0)
- Primary treatment patterns in women recruited to the Australian Ovarian Cancer Study (2012) (0)
- LobSig, a prognostic signature for Invasive Lobular Carcinoma (2019) (0)
- Epigenome erosion and SOX10 drive neural crest phenotypic mimicry in triple-negative breast cancer (2022) (0)
- Mutation and segregation analysis of ATM alleles in 192 Australian breast cancer families. (2003) (0)
- The Australian Ovarian Cancer Study (2012) (0)
- Variation in NFk B Signaling Pathways and Survival in Invasive Epithelial Ovarian Cancer (2014) (0)
- Male breast cancer in BRCA1 and BRCA2 mutation carriers: pathology data from the Consortium of Investigators of Modifiers of BRCA1/2 (2016) (0)
- Genome-wide association analysis of coffee drinking suggests association with CYP1A1CYP1A2 and NRCAM (2012) (0)
- Abstract 4635: Inherited variants affecting RNA editing may contribute to ovarian cancer susceptibility (2015) (0)
- Abstract P6-10-06: Rational combination therapy against triple-negative breast cancer (2012) (0)
- Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes (2020) (0)
- Genome-wide association study of germline variants and breast cancer-specific mortality (2019) (0)
- Abstract 797: A splicing variant of TERT identified by GWAS interacts with menopausal estrogen therapy in risk of ovarian cancer (2016) (0)
- Abstract P2-10-01: The BRCA-1 polymorphism (major homozygous rs5820483) is associated with higher expression of phosphorylated -IGF-1 receptor (2016) (0)
- Correction: Evaluation of copy-number variants as modifiers of breast and ovarian cancer risk for BRCA1 pathogenic variant carriers (2018) (0)
- Abstract 3285: Functional analysis of the 9p22 locus implicates the transcriptional regulation ofBNC2as a mechanism in ovarian cancer predisposition (2014) (0)
- Nicholas Gordon Martin (2020) (0)
- Title : Gene expression profiling of tumour epithelial and stromal compartments during breast cancer progression Short running title : Understanding progression of DCIS to IDC (2014) (0)
- Evaluation of copy-number variants as modifiers of breast and ovarian cancer risk for BRCA1 pathogenic variant carriers (2017) (0)
- LobSig, a prognostic signature for ILC (2019) (0)
- Genome-wide association study of paclitaxel and carboplatin disposition in women with epithelial ovarian cancer (2018) (0)
- Abstract 4729: A genome-wide association study of ovarian cancer prognosis identifies a novel locus for aggressive serous cancer on 19p13 (2010) (0)
- Identification of a genetic variant associated with treatment outcome in ovarian cancer: the potential role of cholesterol metabolism as a determinant of response to chemotherapy (2012) (0)
- Annexin A1 expression in breast cancer: tumor subtypes and prognosis (2015) (0)
- Guidelines for whole genome bisulphite sequencing of intact and FFPET DNA on the Illumina HiSeq X Ten (2018) (0)
- Rare copy number variants (CNVs) and breast cancer risk (2021) (0)
- CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers (2021) (0)
- CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers (2021) (0)
- Abstract 4634: Variants within super-enhancer regulatory elements associate with epithelial ovarian cancer risk (2015) (0)
- Title Interplay between BRCA 1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer (2012) (0)
- Polygenic risk modeling for prediction of epithelial ovarian cancer risk (2022) (0)
- Generation of an ATM knock in mouse with the breast-cancer susceptibility mutation, 7271T>G (2006) (0)
- Abstract 2271: Pathway analysis suggests biological processes driven by germline genetic associations with breast cancer prognosis (2018) (0)
- Abstract 1660: Cholesterol efflux transporter gene expression predicts clinical outcome in serous ovarian cancer (2011) (0)
- Refined histopathological predictors of BRCA1 and BRCA2mutation status: a large-scale analysis of breast cancer characteristics from the BCAC, CIMBA, and ENIGMA consortia (2014) (0)
- Abstract 313: Examining the role of ABCA1 cholesterol transporter in ovarian cancer spheroids (2015) (0)
- Abstract 4648: How inherited mutations affect single cells within the tumor microenvironment in breast tumors stratified by receptor status (2023) (0)
- Abstract 3286: Identification of genetic loci associated with ovarian cancer prognosis (2014) (0)
- Abstract 3860: New ovarian cancer susceptibility loci identified (2010) (0)
- Identification of Ovarian Cancer Susceptibility Genes Involved in Stromal-Epithelial Interactions (2009) (0)
- Abstract 3283: GWAS identifies risk variants for mucinous ovarian carcinoma (2014) (0)
- RELATIONSHIP BETWEEN POLYMORPHISMS IN THE PROGESTERONE AND TYPE I TGF-BETA RECEPTORS AND OVARIAN CANCER RISK (2004) (0)
- Exploring the HER3 tyrosine kinase as a therapeutic target for treatment of brain metastases (2015) (0)
- CYP3A7*1C allele: linking premenopausal oestrone and progesterone levels with risk of hormone receptor-positive breast cancers (2021) (0)
- Morphological and molecular analysis of a breast cancer cluster at the ABC Studio in Toowong. (2012) (0)
- Identification of independent association signals and putative functional variants for breast cancer risk through fine-scale mapping of the 12p11 locus (2016) (0)
- Drug repositioning opportunities for breast cancer prevention and treatment (2019) (0)
- OP-JNCI200057 329..337 (2021) (0)
- Abstract 5493: Genome-wide study of carboplatin and paclitaxel disposition in ovarian cancer patients (2015) (0)
- Abstract 4636: Investigation of exome variants associated with overall survival in ovarian cancer (2015) (0)
- Male breast cancer in BRCA1 and BRCA2 mutation carriers (2018) (0)
- Polygenic risk modeling for prediction of epithelial ovarian cancer risk (2022) (0)
- Combined Hardening of Composite Materials Based on Aluminum (2002) (0)
- The challenges of finding the gene responsible for a rare, autosomal dominant gastric cancer susceptibility syndrome (2012) (0)
This paper list is powered by the following services:
Other Resources About Georgia Chenevix-Trench
What Schools Are Affiliated With Georgia Chenevix-Trench?
Georgia Chenevix-Trench is affiliated with the following schools:
